Results 41 to 50 of about 249,977 (204)

Endomyocardial biopsy under echocardiographic monitoring

, 2016
Endomyocardial biopsy is a common procedure for monitoring cardiac allograft rejection; several techniques have been described so far, throughout different access sites and under echocardiographic or X-ray control.
D'Amico, Gianpiero, Fedrigo, Marny, Bagozzi, Lorenzo, Toscano, Giuseppe, Guariento, Alvise, Gerosa, Gino, Gambino, Antonio   +6 more
core   +1 more source

Endomyocardial biopsy in patients with acute myocarditis, idiopathic dilated cardiomyopathy, and arrhythmogenic right ventricular dysplasia [PDF]

, 2018
Endomyocardial biopsy (EMB) is useful for the diagnosis of myocarditis, cardiac sarcoidosis, and non-ischemic cardiomyopathy. In this mini-review, we discuss the diagnostic potential of EMB in cases of acute/chronic-active myocarditis, sarcoidosis ...
Fontaine, Guy H, Li, Guoliang, Saguner, Ardan M   +2 more
core   +2 more sources

echocardiographic examinations after endomyocardial biopsy

, 2011
Das Auftreten von Perikardergüssen als Zeichen einer traumatisch bedingten Ventrikelperforation nach Endomyokardbipsie als schwerste auftretende Komplikation mit Ausbildung einer Perikardtamponade wurde anhand von 723 Fällen nach Häufigkeit und Klinik ...
Wohlmann, Christoph (130539694)
core   +1 more source

Role of endomyocardial biopsy in rejection surveillance after heart transplantation in neonates and children [PDF]

, 1994
Objectives. The aim of this study was to retrospectively evaluate the sensitivity of noninvasive surveillance (physical examination, echocardiography) of rejection in accurately predicting histologically documented rejection episodes.
Carl L. Backer, Constantine Mavroudis, Lynch, Patricia, Elfriede Pahl, Zales, Vincent R., Webb, Catherine L., Mavroudis, Constantine, Crawford, Susan, Woodrow Benson, D., Vincent R. Zales, D. Woodrow Benson, Susan Crawford, Pahl, Elfriede, Patricia Lynch, Catherine L. Webb, Backer, Carl L.   +15 more
core   +1 more source

Targeted treatment in viral‐associated inflammatory cardiomyopathy

Clinical Case Reports, 2021
Detection of viruses like HHV‐6 in endomyocardial biopsy or serum serology of patients with myocarditis or heart failure features unresponsive to conventional heart failure therapies could be a potential targeted treatment especially in refractory cases.
Ahmad Amin, Sepideh Taghavi, Maryam Chenaghlou, Elahe Zare, Monireh Kamali, Nasim Naderi   +5 more
doaj   +1 more source

Cardiovascular toxicity from immune checkpoint inhibitor therapy: an inflammatory continuum

British Journal of Pharmacology, EarlyView.
Immune checkpoint inhibitor (ICI) therapy has markedly improved outcomes in advanced malignancies but has also revealed a distinct spectrum of cardiovascular immune‐related adverse events. Myocarditis represents the most severe manifestation, while non‐inflammatory left ventricular dysfunction and vascular inflammation have emerged as additional ...
Fabrice Reyes, Florian Buehning, Tobias Lerchner, Julia Vogel, Raluca I. Mincu, Matthias Totzeck, Tienush Rassaf, Lars Michel   +7 more
wiley   +1 more source

Acute myocarditis after COVID‐19 vaccination with mRNA‐1273 in a patient with former SARS‐CoV‐2 infection

ESC Heart Failure, 2021
We describe a case of a 20‐year‐old healthy man developing chest pain and classical symptoms of vaccine reactogenicity 12 h after receiving the first dose of mRNA‐1273 (Moderna).
Tien Dung Nguyen, Gerhard Mall, Julian Georg Westphal, Oliver Weingärtner, Sven Möbius‐Winkler, Paul Christian Schulze   +5 more
doaj   +1 more source

Refining the treatment of immune checkpoint inhibitor–associated myocarditis: Challenges, innovations and rechallenge considerations

British Journal of Pharmacology, EarlyView.
Immune checkpoint inhibitor (ICI)‐associated myocarditis has emerged as a severe and clinically complex immune‐related toxicity that poses significant challenges for therapeutic decision‐making in routine cardio‐oncological care. High‐dose corticosteroids remain the first‐line therapy, yet their timing, dosage and tapering require careful clinical ...
Raluca I. Mincu, Lisa Zimmer, Dimitra Vlachopoulou, Elias Haj‐Yehia, Julia Hoffmann, Lars Michel, Elisabeth Livingstone, Dirk Schadendorf, Alpaslan Tasdogan, Matthias Totzeck, Tienush Rassaf   +10 more
wiley   +1 more source

Myocardial Immunocompetent Cells and Macrophage Phenotypes as Histopathological Surrogates for Diagnosis of Cardiac Sarcoidosis in Japanese

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2016
BackgroundThe histological diagnosis of cardiac sarcoidosis (CS) is based on the presence of myocardial granulomas; however, the sensitivity of endomyocardial biopsy is relatively low.
Yasuyuki Honda, Toshiyuki Nagai, Yoshihiko Ikeda, Mamoru Sakakibara, Naoya Asakawa, Nobutaka Nagano, Michikazu Nakai, Kunihiro Nishimura, Yasuo Sugano, Keiko Ohta‐Ogo, Yasuhide Asaumi, Takeshi Aiba, Hideaki Kanzaki, Kengo Kusano, Teruo Noguchi, Satoshi Yasuda, Hiroyuki Tsutsui, Hatsue Ishibashi‐Ueda, Toshihisa Anzai   +18 more
doaj   +1 more source

Immune checkpoint inhibitor‐induced arrhythmias: Mechanistic insights from clinical and preclinical studies

British Journal of Pharmacology, EarlyView.
Immune checkpoint inhibitors (ICIs) have transformed cancer therapy, but their efficacy continues to be limited by immune‐related adverse events. Among these, ICI‐induced cardiac arrhythmias are increasingly recognised as a major adverse reaction, encompassing a broad spectrum of clinical phenotypes, including conduction blocks, atrial fibrillation and
Anand R. Ramalingam, Zoltán Márton Köhler, Péter Ferdinandy, Zoltán V. Varga   +3 more
wiley   +1 more source